000 | 01880 a2200493 4500 | ||
---|---|---|---|
005 | 20250516092641.0 | ||
264 | 0 | _c20120601 | |
008 | 201206s 0 0 ukr d | ||
022 | _a2522-9028 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStrutyns'kyĭ, R B | |
245 | 0 | 0 |
_a[The changes of metabolism in myocardium at ischemia-reperfusion and activating of the ATP-sensitive potassium channels]. _h[electronic resource] |
260 |
_bFiziolohichnyi zhurnal (Kiev, Ukraine : 1994) _c2012 |
||
300 |
_a13-26 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aArachidonic Acid _xantagonists & inhibitors |
650 | 0 | 4 |
_aArginase _xantagonists & inhibitors |
650 | 0 | 4 |
_aArginine _xmetabolism |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aEicosanoids _xantagonists & inhibitors |
650 | 0 | 4 |
_aGuanosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aHeme |
650 | 0 | 4 |
_aKATP Channels _xagonists |
650 | 0 | 4 |
_aMitochondria, Heart _xdrug effects |
650 | 0 | 4 |
_aMitochondrial Membrane Transport Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMitochondrial Permeability Transition Pore |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aNitrate Reductase (NADH) _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide _xagonists |
650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
650 | 0 | 4 |
_aPinacidil _xadministration & dosage |
650 | 0 | 4 |
_aReactive Nitrogen Species _xmetabolism |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
700 | 1 | _aKotsiuruba, A V | |
700 | 1 | _aNeshcheret, O P | |
700 | 1 | _aRovenets', R A | |
700 | 1 | _aMoĭbenko, O O | |
773 | 0 |
_tFiziolohichnyi zhurnal (Kiev, Ukraine : 1994) _gvol. 58 _gno. 1 _gp. 13-26 |
|
999 |
_c21785821 _d21785821 |